In this episode, Brent speaks with physician-scientist Dr. Loren Walensky to explore the rapidly growing world of peptides, GLP-1 drugs, and experimental health interventions. As compounds like semaglutide, BPC-157, and other peptides gain popularity in wellness and longevity circles, Walensky explains the critical difference between therapies that have been rigorously tested and those that are being used long before the science is settled. The conversation covers obesity, willpower, off-label prescribing, the role of the FDA, and why promising treatments still need evidence before they can be considered safe and effective. He's as credentialed as you can get on this topic, hope you enjoy.
Podden och tillhörande omslagsbild på den här sidan tillhör
Brent Franson. Innehållet i podden är skapat av Brent Franson och inte av,
eller tillsammans med, Poddtoppen.
